Effect of Glycodelin on the Cytokine Profile of Rats during Allogeneic Bone Marrow Cell Transplantation
- PMID: 36210410
- DOI: 10.1007/s10517-022-05603-2
Effect of Glycodelin on the Cytokine Profile of Rats during Allogeneic Bone Marrow Cell Transplantation
Abstract
The protein glycodelin (PP14, PAEP) is associated with pregnancy and exhibits pronounced immunotropic properties. We studied the effect of glycodelin on the cytokine profile of blood serum during transplantation a suspension of allogeneic red bone marrow cells to Wistar rats. Recombinant glycodelin was administered to the animals 4 times (14 μg each time). Against the background of bone marrow cell transplantation, the levels of proinflammatory (IL-1α, IL-1β, and IL-18) and regulatory (IL-7, IL-12) cytokines and CSF (M-CSF) increased in blood serum, which indicates a systemic inflammatory response to the allograft. Glycodelin administration against the background of bone marrow cell allotransplantation led to a significant decrease in the proinflammatory cytokine IL-17A on day 21 of the experiment; the concentrations of the other cytokines remained unchanged. In general, glycodelin can suppress the level of IL-17A, a marker of graft rejection, which opens perspectives for its further investigation as a potential drug.
Keywords: Wistar rats; allogeneic transplant; cytokine profile; glycodelin.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.Ann Hematol. 1993 Dec;67(6):267-76. doi: 10.1007/BF01696346. Ann Hematol. 1993. PMID: 7506580 Clinical Trial.
-
In vivo administration of granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage CSF, interleukin-1 (IL-1), and IL-4, alone and in combination, after allogeneic murine hematopoietic stem cell transplantation.Blood. 1991 Mar 15;77(6):1376-82. Blood. 1991. PMID: 1705839
-
Serum interleukin-3 levels following autologous or allogeneic bone marrow transplantation: effects of T-cell depletion, blood stem cell infusion, and hematopoietic growth factor treatment.Blood. 1993 Apr 1;81(7):1915-22. Blood. 1993. PMID: 8096407
-
Clinical use of hematopoietic growth factors in allogeneic bone marrow transplantation.Blood Rev. 1994 Sep;8(3):169-78. doi: 10.1016/0268-960x(94)90078-v. Blood Rev. 1994. PMID: 7529606 Review.
-
[Use of cytokines in allogeneic bone marrow transplantation].Acta Haematol Pol. 1994;25(2 Suppl 1):84-94. Acta Haematol Pol. 1994. PMID: 8067213 Review. Polish.
References
-
- Bochkova MS, Zamorina SA, Timganova VP, Khramtsov PV, Rayev MB. The role of glycodelin in the regulation of the immune system in the context of developing pregnancy. Med. Immunol. 2019;21(4):603-616. Russian. https://doi.org/10.15789/1563-0625-2019-4-603-616
-
- Alok A, Karande AA. The role of glycodelin as an immune-modulating agent at the feto-maternal interface. J. Reprod. Immunol. 2009;83(1-2):124-127. https://doi.org/10.1016/j.jri.2009.06.261 - DOI - PubMed
-
- Dixit A, Balakrishnan B, Karande AA. Immunomodulatory activity of glycodelin: implications in allograft rejection. Clin. Exp. Immunol. 2018;192(2):213-223. https://doi.org/10.1111/cei.13096 - DOI - PubMed - PMC
-
- Ogonek J, Kralj Juric M, Ghimire S, Varanasi PR, Holler E, Greinix H, Weissinger E. Immune reconstitution after allogeneic hematopoietic stem cell transplantation. Front. Immunol. 2016;7:507. https://doi.org/10.3389/fimmu.2016.00507 - DOI - PubMed - PMC
-
- Henden AS, Hill GR. Cytokines in graft-versus-host disease. J. Immunol. 2015;194(10):4604-4612. https://doi.org/10.4049/jimmunol.1500117 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous